2,5-di-tert-butylbenzoquinone has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clunes, MT; Kemp, PJ | 1 |
1 other study(ies) available for 2,5-di-tert-butylbenzoquinone and Adenocarcinoma
Article | Year |
---|---|
P2u purinoceptor modulation of intracellular Ca2+ in a human lung adenocarcinoma cell line: down-regulation of Ca2+ influx by protein kinase C.
Topics: Adenocarcinoma; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Benzoquinones; Caffeine; Calcium; Down-Regulation; Enzyme Inhibitors; Humans; Lung Neoplasms; Phosphodiesterase Inhibitors; Protein Kinase C; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Thapsigargin; Thionucleotides; Tumor Cells, Cultured; Uridine Triphosphate | 1996 |